{"gene":"ABCB11","run_date":"2026-06-09T22:02:36","timeline":{"discoveries":[{"year":2000,"finding":"BSEP (Bsep) mediates ATP-dependent transport of monoanionic bile salts in Sf9 cell vesicles; cyclosporin A, rifamycin SV, rifampicin, and glibenclamide cis-inhibit Bsep-mediated bile salt transport; estradiol-17β-glucuronide (E217G) trans-inhibits Bsep only after its Mrp2-dependent secretion into bile canaliculi, establishing that E217G requires Mrp2 to exert its cholestatic effect on Bsep.","method":"ATP-dependent vesicle transport assays in Bsep-, Mrp2-, and Bsep/Mrp2-expressing Sf9 cells; rapid filtration technique; canalicular plasma membrane vesicles from rat liver","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted in vitro transport activity in defined expression systems, multiple orthogonal inhibitor and substrate tests, mechanistic dissection with Mrp2-deficient membranes","pmids":["10648470"],"is_preprint":false},{"year":1998,"finding":"In endotoxin-treated rats, both mRNA and protein levels of Spgp (BSEP/ABCB11) are decreased, and the normally sharp canalicular localization shifts to a fuzzy subapical pattern, indicating that endotoxin-induced cholestasis involves both reduced BSEP expression and abnormal subcellular localization.","method":"RT-PCR, Western blotting of membrane fractions, confocal scanning laser microscopy in endotoxin-treated rats","journal":"Hepatology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two orthogonal methods (protein and mRNA quantification plus immunolocalization), single lab","pmids":["9828229"],"is_preprint":false},{"year":2001,"finding":"Knockout of the spgp (Abcb11) gene in mice causes intrahepatic cholestasis with greatly reduced cholic acid secretion (~6% of wild-type); however, total bile salt output is ~30% of wild-type due to secretion of tetra-hydroxylated bile acids and an alternative canalicular transport mechanism, indicating that BSEP is the primary but not sole canalicular bile acid transporter. Abcb11 knockout also increases biliary cholesterol and phospholipid secretion, suggesting intrahepatic bile salts drive biliary lipid secretion.","method":"Targeted gene knockout in mice; bile collection and HPLC analysis of bile composition; comparison with wild-type controls","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined biliary phenotype, multiple biochemical readouts, replicated by subsequent studies","pmids":["11172067"],"is_preprint":false},{"year":2003,"finding":"E217G induces endocytic internalization of Bsep from the canalicular membrane in rat liver, dependent on prior Mrp2-mediated secretion of E217G into bile canaliculi; dibutyryl-cAMP (DBcAMP) prevents both cholestasis and Bsep internalization by stimulating insertion of canalicular transporter-containing vesicles.","method":"Confocal microscopy and Western blotting of rat liver after E217G administration; hepatocyte couplet fluorescent bile salt accumulation assay; use of TR- (Mrp2-deficient) rats as controls","journal":"American Journal of Physiology - Gastrointestinal and Liver Physiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (confocal microscopy, Western blot, functional transport assay), genetic control (Mrp2-deficient rats), replicated mechanistic finding","pmids":["12702498"],"is_preprint":false},{"year":2001,"finding":"Bsep localization in rat liver is dynamically regulated by osmolarity: hypoosmolarity recruits intracellular Bsep vesicles to the canalicular membrane (choleresis), whereas hyperosmolarity causes retrieval of Bsep from the canalicular membrane (cholestasis). Bsep and Mrp2 occupy largely separate intracellular vesicle populations (colocalization in only 15% of intracellular vesicles) during retrieval.","method":"Immunohistochemistry, confocal microscopy, and densitometry in perfused rat liver under defined osmotic conditions","journal":"Hepatology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization by confocal microscopy with functional bile flow correlate, single lab","pmids":["11230729"],"is_preprint":false},{"year":2005,"finding":"The two most common PFIC2 mutations E297G and D482G result in impaired membrane trafficking of BSEP: both mutants predominantly undergo only core glycosylation and are retained in the endoplasmic reticulum; proteasome inhibitor MG132 causes cellular accumulation of the core-glycosylated forms. Despite impaired trafficking, transport function (taurocholate/glycocholate) of the mutants per se is not significantly reduced.","method":"Site-directed mutagenesis of human BSEP; expression in HEK293 and MDCK II cells; membrane vesicle transport assays; glycosylation analysis; proteasome inhibition with MG132","journal":"Hepatology","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis combined with multiple biochemical assays (glycosylation, transport, proteasome inhibition) in two cell lines","pmids":["15791618"],"is_preprint":false},{"year":2005,"finding":"BSEP can transport the non-bile acid substrate pravastatin in an ATP-dependent manner; human BSEP shows 3.3-fold higher relative uptake of pravastatin vs. taurocholate compared to rat Bsep; pravastatin and taurocholate competitively interact with human BSEP (Km for pravastatin ~124 µM). Several statins inhibit BSEP-mediated taurocholate transport with hydrophilic statins being weaker inhibitors.","method":"ATP-dependent uptake assay in membrane vesicles from hBSEP- and rBsep-expressing cells; competitive inhibition studies; species comparison","journal":"Journal of Pharmacology and Experimental Therapeutics","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstituted transport assay with defined kinetics and competitive inhibition analysis","pmids":["15901796"],"is_preprint":false},{"year":2006,"finding":"Vectorial transcellular transport of bile salts (basal-to-apical) is reconstituted in LLC-PK1 cells co-expressing NTCP and BSEP; cells expressing only one transporter show no vectorial transport. Substrate specificity reveals BSEP preferentially transports unconjugated bile salts and glycine conjugates over taurine conjugates, with no transport of lithocholate.","method":"Double transfection of LLC-PK1 cells with human NTCP+BSEP or rat Ntcp+Bsep; directional flux measurements; substrate clearance calculations","journal":"American Journal of Physiology - Gastrointestinal and Liver Physiology","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted vectorial transport in defined cell system, systematic substrate specificity analysis across species","pmids":["16474011"],"is_preprint":false},{"year":2006,"finding":"N-linked glycosylation is required for BSEP protein stability, intracellular trafficking, and transport function: removal of glycans accelerates proteasomal degradation; proteins with fewer than two N-linked glycans fail to reach the apical membrane and are degraded by the proteasome (MG132-sensitive). At least two N-linked glycans (at Asn109, Asn116, Asn122, Asn125) are required for stable apical membrane expression.","method":"Site-directed mutagenesis of N-glycosylation sites in rat Bsep-YFP; expression in MDCK II cells; immunoblot, glycosidase cleavage, half-life measurements, proteasome inhibition, taurocholate transport assay","journal":"American Journal of Physiology - Gastrointestinal and Liver Physiology","confidence":"High","confidence_rationale":"Tier 1 / Strong — systematic mutagenesis of four glycosylation sites with biochemical half-life, localization, and functional transport readouts","pmids":["17082223"],"is_preprint":false},{"year":2007,"finding":"Clinical phenotype severity (PFIC2 > BRIC2) correlates with the level of BSEP plasma membrane expression: PFIC2 mutant D482G shows the greatest reduction in plasma membrane protein, while BRIC2 mutants (A570T, R1050C) show intermediate reduction. All mutants accumulate in perinuclear aggresome-like structures upon proteasome inhibition, indicating ubiquitin-dependent degradation; treatment with reduced temperature, sodium butyrate, or 4-phenylbutyrate rescues D482G surface expression.","method":"Expression of mutant rat Bsep in HEK293 cells; cell surface biotinylation; confocal microscopy; proteasome inhibition with MG132; pharmacological chaperone rescue","journal":"American Journal of Physiology - Cell Physiology","confidence":"High","confidence_rationale":"Tier 1 / Strong — systematic panel of mutations with surface biotinylation, localization, and pharmacological rescue, multiple orthogonal methods","pmids":["17855769"],"is_preprint":false},{"year":2007,"finding":"BSEP transport function is impaired in proportion to accelerated protein degradation in disease mutants; BRIC2 mutants (A570T, R1050C) retain ~50% taurocholate transport and longer half-life, while most PFIC2 mutants have near-absent transport. The C-terminal tail (R1057X truncation) is required for transport activity but not for correct targeting to the apical membrane.","method":"Mutagenesis of rat Bsep in MDCK II cells; taurocholate transport assay; protein half-life measurement; subcellular distribution by confocal microscopy in polarized monolayers","journal":"American Journal of Physiology - Gastrointestinal and Liver Physiology","confidence":"High","confidence_rationale":"Tier 1 / Strong — systematic mutant panel with transport kinetics, protein half-life, and localization in polarized cells","pmids":["17947449"],"is_preprint":false},{"year":2008,"finding":"Cell-surface-resident BSEP undergoes short-chain ubiquitination (addition of 2–3 ubiquitins, shifting molecular mass from ~170 to ~190 kDa); ubiquitination accelerates BSEP degradation from the cell surface. PFIC2 mutations E297G and D482G enhance BSEP ubiquitination (increasing degradation rate), while 4-phenylbutyrate (4PBA) reduces ubiquitination and prolongs surface BSEP half-life.","method":"Ubiquitin modification assay in MDCK II cells and rat canalicular membrane vesicles; biotin-labeling of cell-surface proteins; chimeric ubiquitin-BSEP fusion construct; 4PBA treatment","journal":"Molecular Pharmacology","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct biochemical demonstration of ubiquitin modification, mutagenesis, and pharmacological modulation with in vitro and in vivo corroboration","pmids":["18829893"],"is_preprint":false},{"year":2009,"finding":"ABCB11 missense mutations and SNPs impair BSEP at two distinct levels: (1) reduced wild-type pre-mRNA splicing (up to 95% reduction in normal transcript for some mutations; D482G enhances aberrant splicing); (2) ER retention and proteasomal degradation of most missense mutant proteins. Treatment with glycerol or reduced temperature rescues processing of several mutants including E297G. Two assessed mutants (N490D, A570T) show reduced taurocholate transport activity. The SNP A444 shows reduced protein compared to V444.","method":"In vitro minigene splicing assay; expression in CHO-K1 cells; immunofluorescence for ER colocalization; glycerol/low-temperature chaperone rescue; membrane vesicle taurocholate transport assay; exogenous splicing factor addition","journal":"Hepatology","confidence":"High","confidence_rationale":"Tier 1 / Strong — comprehensive analysis of 80% of known mutations using multiple orthogonal methods (splicing assay, protein processing, transport activity) in a single systematic study","pmids":["19101985"],"is_preprint":false},{"year":2006,"finding":"Oxidative stress internalizes Bsep from the canalicular membrane and impairs bile salt secretion through a Ca2+-dependent, PKC-mediated mechanism; PKC inhibition (H7, staurosporine, Gö6976) or PKA activation (dibutyryl-cAMP) prevents and reverses Bsep internalization and bile salt secretory failure. F-actin disarrangement accompanies Bsep internalization.","method":"Pro-oxidant treatment of isolated rat hepatocyte couplets; fluorescent bile salt analog (CLF) accumulation assay; Bsep immunofluorescence; pharmacological kinase inhibitors/activators; intracellular Ca2+ chelation","journal":"Toxicological Sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple pharmacological tools in functional assay with localization readout, single lab","pmids":["16452108"],"is_preprint":false},{"year":2011,"finding":"The Src family kinase Fyn (but not Yes or c-Src) mediates hyperosmolarity-induced retrieval of Bsep and Mrp2 from the canalicular membrane; this is driven by NADPH oxidase-derived reactive oxygen species and involves Fyn-dependent phosphorylation of cortactin underneath the canalicular membrane. JNK activation is not involved in transporter retrieval.","method":"Perfused rat liver with hyperosmotic buffer; pharmacological Src kinase inhibitors (PP-2, SU6656); p47phox knockout mice; NAC/apocynin as ROS scavengers; Fyn knockdown; cortactin phosphorylation assay; biliary excretion of fluorescent substrates","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — epistasis via genetic KO (p47phox), kinase-selective pharmacological dissection, knockdown, and functional biliary readout","pmids":["22057277"],"is_preprint":false},{"year":2014,"finding":"LKB1 activity is required for microtubule-dependent trafficking of ABCB11 to the canalicular membrane; LKB1 knockout hepatocytes show impaired ABCB11 trafficking and canalicular network formation. In control hepatocytes, ABCB11 traffics through the rab11a–myosin Vb recycling endosomal system and its trafficking is accelerated by taurocholate (via AMPK) and cAMP (via PKA). In LKB1 KO cells, only cAMP/PKA (not taurocholate) restores trafficking.","method":"Liver-specific LKB1 knockout mice; collagen sandwich hepatocyte cultures; live cell imaging; FRAP; particle tracking; Western blotting; pharmacological cAMP and AMPK manipulation","journal":"PLoS One","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with functional phenotype, multiple live-cell imaging methods, pharmacological epistasis dissecting LKB1/AMPK vs. PKA pathways","pmids":["24643070"],"is_preprint":false},{"year":2003,"finding":"Hepatic overexpression of Abcb11 in transgenic mice increases bile flow and biliary secretion of bile salts, phosphatidylcholine, and cholesterol; it activates FXR/SHP target genes (ileal lipid-binding protein, SHP upregulated; CYP7A1 and ASBT downregulated) by increasing hydrophobic bile salt pool and FXR ligand taurodeoxycholate 4-fold. Abcb11 transgenic mice are resistant to diet-induced hepatic steatosis, establishing ABCB11 as rate-limiting for hepatobiliary bile salt secretion with downstream effects on energy homeostasis.","method":"Transthyretin-Abcb11 and BAC-Abcb11 transgenic mice; bile collection; HPLC bile salt analysis; hepatic gene expression by Northern blot/RT-PCR; lithogenic diet challenge","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — two independent transgenic lines, multiple biochemical and gene expression readouts, diet challenge functional test","pmids":["14570929"],"is_preprint":false},{"year":2005,"finding":"In spgp (Abcb11) knockout mice, elevated Mdr1 (P-glycoprotein) expression serves as an alternative bile acid transport pathway; membrane vesicles from Mdr1-overexpressing drug-resistant cells transport bile acids with ~5-fold lower affinity than Spgp, providing the first direct evidence that P-glycoprotein can transport bile acids.","method":"Western blotting of ABC transporters in Abcb11 KO mice; ATP-dependent bile acid transport assay in plasma membrane vesicles from Mdr1-overexpressing cell line","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro transport reconstitution combined with KO mouse expression data, single lab","pmids":["16156672"],"is_preprint":false},{"year":2009,"finding":"Membrane cholesterol content modulates BSEP transport kinetics: cholesterol loading increases Vmax for bile salt transport in BSEP/Bsep from all three species (human, rat, mouse) without substantially changing Km. The effect is most pronounced in rat Bsep. Cholesterol-loaded vesicles also partially rescue transport activity of disease mutants E297G and R432T.","method":"Baculovirus Sf9 expression of human/rat/mouse BSEP; cholesterol loading with cholesterol-cyclodextrin complex; kinetic transport assays with four conjugated bile salts; species-specific inhibitor IC50 determinations","journal":"Drug Metabolism and Disposition","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro kinetic analysis across three species with defined cholesterol manipulation, single lab","pmids":["19520776"],"is_preprint":false},{"year":2004,"finding":"LPS downregulates human MRP2 and BSEP protein in liver slices without affecting their mRNA levels, demonstrating that LPS-induced reduction of these transporters in humans occurs via posttranscriptional mechanisms (in contrast to rat, where bsep mRNA is not affected while mrp2 mRNA is reduced).","method":"Precision-cut human and rat liver slices treated with LPS; RT-PCR for mRNA; immunofluorescence microscopy for protein; nitrate/nitrite and cytokine measurements","journal":"American Journal of Physiology - Gastrointestinal and Liver Physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — parallel mRNA and protein quantification in human and rat tissue with defined species-specific conclusions, single lab","pmids":["15205115"],"is_preprint":false},{"year":2007,"finding":"Periportal downregulation of Bsep in obstructive cholestasis (bile duct ligation) is mediated by TNF-α and IL-1β: cytokine inactivation prevents periportal Bsep reduction, while portal inflammation and predominantly periportal IL-1β induction colocalizes with the zone-specific transporter changes.","method":"Bile duct ligation in rats; semiquantitative immunofluorescence with zonal analysis; cytokine neutralization with anti-TNF-α and anti-IL-1β antibodies; LPS comparison","journal":"American Journal of Physiology - Gastrointestinal and Liver Physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cytokine neutralization epistasis with spatial resolution, single lab","pmids":["17916651"],"is_preprint":false},{"year":2013,"finding":"Human BSEP (ABCB11) was heterologously expressed and purified from Pichia pastoris; BSEP-GFP localizes to the plasma membrane of P. pastoris; purified BSEP in appropriate detergents binds to ATP-agarose, confirming ATP-binding capability of the isolated protein.","method":"Heterologous expression in Pichia pastoris; confocal laser scanning microscopy; detergent screening (>100 detergents); FSEC; ATP-agarose binding assay; purification yielding ~1 mg/100g wet cells","journal":"PLoS One","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — first purification of human BSEP with ATP-binding validation, single lab, no full functional reconstitution reported","pmids":["23593265"],"is_preprint":false},{"year":2014,"finding":"Membrane cholesterol differentially modulates MRP2 and BSEP transport kinetics: for BSEP variants p.V444 and p.A444, cholesterol increases Vmax without changing Km; for BSEP mutants p.E297G and p.R432T, high cholesterol increases transport activity but does not reach wild-type capacity. MRP2 cholesterol effects differ, showing cooperative kinetics for E17βG that shift to Michaelis-Menten at high cholesterol.","method":"Baculovirus expression of BSEP variants and mutants in insect cells; cholesterol loading; kinetic transport assays; Hanes-Woolf analysis","journal":"Molecular Pharmacology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — systematic kinetic analysis with defined mutants and cholesterol manipulation, single lab","pmids":["24711118"],"is_preprint":false},{"year":2005,"finding":"Novel ABCB11 mutations R432T and E297G (compound heterozygous) found in a BRIC2 patient reduce taurocholate transport to 13% and 20% of reference levels respectively in SF9 cells, while hepatic BSEP expression is preserved (unlike PFIC2 where it is absent), providing direct in vitro evidence for partial loss-of-function causing the benign rather than progressive phenotype.","method":"ABCB11 sequencing; taurocholate transport assay in SF9-transfected cells; immunohistochemistry of liver biopsy","journal":"Journal of Hepatology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro functional transport assay combined with in vivo protein expression, single lab, limited to two mutations","pmids":["16039748"],"is_preprint":false},{"year":2020,"finding":"The PFIC2 mutation p.T463I (located in a conserved ABC transporter motif predicted by 3D modelling to impair ATP-binding) reduces taurocholate transport to near-zero despite normal canalicular membrane targeting; ivacaftor treatment increases transport activity of BsepT463I by 1.7-fold, restoring it to 95% of wild-type activity.","method":"3D structure modelling; site-directed mutagenesis; expression in Can10 cells (localization) and MDCK clones co-expressing rat Ntcp (transport); ivacaftor treatment; taurocholate transport assay","journal":"Liver International","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — mutagenesis with functional rescue by pharmacological potentiator, single lab","pmids":["32433800"],"is_preprint":false},{"year":2012,"finding":"Abcb11 knockout (C57BL/6J) mice develop cholestasis and show impaired mitochondrial long-chain fatty acid β-oxidation before the onset of cholestasis, with elevated serum free fatty acids, reduced white adipose tissue, increased fatty acid metabolites (phenylpropionylglycine, phenylacetylglycine), and reduced expression of genes for mitochondrial fatty acid oxidation.","method":"Abcb11 KO C57BL/6J mice; hepatic lipid metabolism profiling; metabolomics; gene expression analysis; serum biochemistry","journal":"Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO on defined background with metabolomic and gene expression confirmation, single lab","pmids":["22619174"],"is_preprint":false},{"year":2010,"finding":"In sandwich-cultured human hepatocytes, IL-6 or IL-1β decrease BSEP mRNA while paradoxically increasing BSEP protein levels, revealing a species-specific discrepancy between mRNA and protein regulation; in rat hepatocytes, TNF-α and IL-1β decrease both Bsep mRNA and protein.","method":"Sandwich-cultured human and rat hepatocytes treated with TNF-α, IL-6, IL-1β; Western blot for protein; RT-PCR for mRNA; LPS-treated rat in vivo comparison","journal":"Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — parallel mRNA/protein quantification in both species with in vivo validation in rats, single lab","pmids":["20702406"],"is_preprint":false},{"year":2021,"finding":"Abcb11-deficient mice spontaneously develop HCC and ICC after 12 months; accumulated bile acids in Abcb11-/- livers are predominantly FXR antagonists/non-agonists, causing downregulation of FXR expression and transcriptional activity; FXR agonist obeticholic acid reduces liver injury and tumor incidence in Abcb11-/- mice, establishing a causal link between ABCB11 deficiency, loss of FXR signaling, and hepatocarcinogenesis.","method":"Abcb11-/- mice followed longitudinally; liver histology; RNA-sequencing; bile acid profiling; FXR activity measurement; obeticholic acid treatment rescue experiment","journal":"Journal of Pathology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO mouse with pharmacological rescue (FXR agonist) and transcriptomic mechanism, single lab","pmids":["34410012"],"is_preprint":false}],"current_model":"ABCB11/BSEP is an ATP-binding cassette transporter exclusively expressed at the hepatocyte canalicular membrane where it constitutes the rate-limiting step for bile salt secretion into bile; its transport activity requires at least two N-linked glycans for protein stability and correct trafficking, is regulated by ubiquitin-mediated proteasomal degradation at the cell surface (modulated by disease mutations and 4-phenylbutyrate), is dynamically retrieved from or inserted into the canalicular membrane by osmolarity (via Fyn kinase/ROS), cAMP/PKA, LKB1/AMPK, and endocytic pathways (triggered by oxidative stress, cholestatic agents such as E217G via Mrp2, and inflammatory cytokines via posttranscriptional mechanisms), and its deficiency causes progressive intrahepatic cholestasis, impaired fatty acid β-oxidation, and—through accumulation of FXR-antagonist bile acids—hepatocarcinogenesis."},"narrative":{"mechanistic_narrative":"ABCB11 (BSEP/Spgp) is the ATP-dependent canalicular transporter that constitutes the rate-limiting step for hepatocyte secretion of monoanionic bile salts into bile, driving overall bile flow and biliary lipid secretion [PMID:10648470, PMID:14570929]. Reconstituted in vitro and in double-transfected polarized cells, it mediates vectorial basal-to-apical bile salt transport in concert with the uptake transporter NTCP, preferring unconjugated and glycine-conjugated bile salts and also handling non-bile-acid substrates such as pravastatin [PMID:15901796, PMID:16474011]. Genetic ablation establishes BSEP as the primary but not sole canalicular bile acid pump, with residual output sustained by tetrahydroxylated bile acids and an alternative Mdr1/P-glycoprotein-mediated pathway [PMID:11172067, PMID:16156672]. Its activity is tuned at the membrane by cholesterol content, which raises transport Vmax [PMID:19520776, PMID:24711118]. BSEP biogenesis and surface residence are tightly controlled: at least two N-linked glycans are required for stability and apical targeting, and surface protein is removed by short-chain ubiquitination and proteasomal degradation, a process accelerated by disease mutations and slowed by 4-phenylbutyrate [PMID:17082223, PMID:18829893]. Surface abundance is further set by dynamic vesicular retrieval and insertion governed by osmolarity acting through Fyn kinase and NADPH-oxidase-derived ROS, by cAMP/PKA-stimulated insertion, and by LKB1/AMPK-dependent microtubule trafficking through the rab11a–myosin Vb recycling endosome [PMID:12702498, PMID:11230729, PMID:22057277, PMID:24643070]. Mutations in ABCB11 cause progressive (PFIC2) and benign recurrent (BRIC2) intrahepatic cholestasis, with severity tracking the degree of misprocessing, accelerated degradation, and loss of plasma-membrane expression [PMID:15791618, PMID:17855769, PMID:19101985, PMID:16039748]. Beyond cholestasis, BSEP deficiency impairs mitochondrial fatty acid β-oxidation and, through accumulation of FXR-antagonist bile acids and loss of FXR signaling, promotes hepatocarcinogenesis [PMID:22619174, PMID:34410012].","teleology":[{"year":2000,"claim":"Established that BSEP is a bona fide ATP-dependent bile salt transporter and dissected how a co-secreted compound exerts trans-inhibition only after Mrp2-dependent biliary delivery.","evidence":"ATP-dependent vesicle transport assays in Bsep/Mrp2-expressing Sf9 cells and rat canalicular membrane vesicles with inhibitor panels","pmids":["10648470"],"confidence":"High","gaps":["Did not resolve transport stoichiometry or structural basis of substrate recognition","Mechanism of E217G internalization not addressed at this stage"]},{"year":2001,"claim":"Defined BSEP's in vivo role by showing knockout causes intrahepatic cholestasis yet retains partial bile salt output, revealing BSEP is the primary but not exclusive canalicular bile acid transporter.","evidence":"Targeted Abcb11 knockout mice with bile collection and HPLC composition analysis","pmids":["11172067"],"confidence":"High","gaps":["Identity of the alternative transporter unresolved at this point","Did not address human phenotype correspondence"]},{"year":2001,"claim":"Showed that BSEP surface abundance is dynamically set by membrane retrieval/insertion rather than fixed, linking osmolarity to bile flow.","evidence":"Immunohistochemistry and confocal microscopy in perfused rat liver under defined osmotic conditions","pmids":["11230729"],"confidence":"Medium","gaps":["Signaling intermediates linking osmolarity to retrieval not identified","Single lab, localization-based readout"]},{"year":2003,"claim":"Demonstrated cAMP-stimulated vesicular insertion of BSEP and identified endocytic internalization as a reversible cholestatic mechanism.","evidence":"Confocal microscopy, Western blot, and hepatocyte couplet transport assays in rat liver with Mrp2-deficient controls","pmids":["12702498"],"confidence":"High","gaps":["Endocytic machinery components not identified","Did not define the kinase cascade downstream of cAMP"]},{"year":2003,"claim":"Established ABCB11 as rate-limiting for hepatobiliary bile salt secretion with downstream FXR/SHP and energy-homeostasis consequences.","evidence":"Two independent Abcb11 transgenic mouse lines with bile analysis, hepatic gene expression, and lithogenic diet challenge","pmids":["14570929"],"confidence":"High","gaps":["Mechanism linking bile salt pool to systemic energy metabolism only correlative","FXR ligand changes inferred from pool composition"]},{"year":2005,"claim":"Defined the molecular basis of PFIC2 mutations E297G/D482G as trafficking defects (ER retention, core glycosylation, proteasomal degradation) rather than intrinsic transport loss.","evidence":"Site-directed mutagenesis in HEK293/MDCK cells with glycosylation analysis, transport assays, and MG132 proteasome inhibition","pmids":["15791618"],"confidence":"High","gaps":["E3 ligase mediating degradation not identified","Did not test pharmacological chaperone rescue"]},{"year":2005,"claim":"Broadened BSEP substrate range to non-bile-acid compounds and quantified statin interactions relevant to drug-induced cholestasis.","evidence":"ATP-dependent vesicle uptake assays with kinetic and competitive inhibition analysis across human and rat orthologs","pmids":["15901796"],"confidence":"High","gaps":["In vivo relevance of pravastatin transport not established","Structural basis of statin inhibition unknown"]},{"year":2005,"claim":"Provided direct in vitro evidence that P-glycoprotein/Mdr1 is the compensatory alternative bile acid transporter upregulated in BSEP deficiency.","evidence":"Western blotting of Abcb11 KO mice plus ATP-dependent bile acid transport in Mdr1-overexpressing membrane vesicles","pmids":["16156672"],"confidence":"Medium","gaps":["Physiological contribution in vivo not quantified","Single lab"]},{"year":2005,"claim":"Linked partial loss-of-function transport defects to the milder BRIC2 phenotype, distinguishing it from PFIC2 by preserved hepatic BSEP expression.","evidence":"ABCB11 sequencing with taurocholate transport assays in Sf9 cells and liver biopsy immunohistochemistry","pmids":["16039748"],"confidence":"Medium","gaps":["Limited to two mutations","Single patient/lab"]},{"year":2006,"claim":"Reconstituted vectorial transcellular bile salt transport and defined BSEP substrate preference, establishing the NTCP-BSEP axis.","evidence":"Double-transfected LLC-PK1 cells with directional flux and substrate clearance measurements","pmids":["16474011"],"confidence":"High","gaps":["Did not address regulation of the coupled system","Lithocholate handling left unexplained mechanistically"]},{"year":2006,"claim":"Established N-linked glycosylation as a determinant of BSEP stability, trafficking, and function, with at least two glycans required for apical expression.","evidence":"Site-directed mutagenesis of glycosylation sites in rat Bsep-YFP in MDCK cells with half-life, localization, glycosidase, and transport readouts","pmids":["17082223"],"confidence":"High","gaps":["Which glycan-recognizing quality-control machinery acts on BSEP not identified","Did not address glycan role in human disease variants"]},{"year":2006,"claim":"Identified oxidative stress as an internalizing stimulus acting through a Ca2+/PKC pathway reversible by PKA, with cytoskeletal involvement.","evidence":"Pro-oxidant treatment of rat hepatocyte couplets with kinase inhibitors/activators, Ca2+ chelation, and Bsep immunofluorescence","pmids":["16452108"],"confidence":"Medium","gaps":["Molecular link between PKC and the endocytic machinery undefined","Pharmacological inhibitors lack absolute specificity"]},{"year":2007,"claim":"Connected clinical severity to the level of BSEP plasma-membrane expression and demonstrated ubiquitin-dependent degradation with pharmacological chaperone rescue.","evidence":"Mutant rat Bsep in HEK293 cells with surface biotinylation, confocal imaging, MG132, and temperature/4PBA/butyrate rescue","pmids":["17855769"],"confidence":"High","gaps":["Specific ubiquitin ligase not identified","Rat ortholog used as surrogate for human variants"]},{"year":2007,"claim":"Showed transport function declines in proportion to accelerated degradation and mapped the C-terminal tail as required for transport but not targeting.","evidence":"Mutant rat Bsep in MDCK cells with transport kinetics, half-life, and polarized localization","pmids":["17947449"],"confidence":"High","gaps":["Structural role of the C-terminus in the transport cycle unresolved","Rat surrogate system"]},{"year":2007,"claim":"Identified TNF-α and IL-1β as mediators of zone-specific periportal BSEP downregulation in obstructive cholestasis.","evidence":"Bile duct ligation in rats with zonal immunofluorescence and cytokine neutralization","pmids":["17916651"],"confidence":"Medium","gaps":["Intracellular signaling from cytokine to transporter loss not defined","Single lab"]},{"year":2008,"claim":"Directly demonstrated short-chain ubiquitination of cell-surface BSEP as the degradation signal, modulated by disease mutations and 4PBA.","evidence":"Ubiquitin modification assays in MDCK cells and rat canalicular vesicles with surface biotinylation, chimeric ubiquitin-BSEP, and 4PBA treatment","pmids":["18829893"],"confidence":"High","gaps":["Responsible ubiquitin ligase and deubiquitinase unidentified","Recognition signal on BSEP not mapped"]},{"year":2009,"claim":"Systematically dissected ABCB11 mutations into pre-mRNA splicing defects versus protein ER-retention/degradation defects, with chaperone-rescuable subsets.","evidence":"Minigene splicing assays, CHO-K1 expression with ER colocalization, glycerol/temperature rescue, and transport assays across most known mutations","pmids":["19101985"],"confidence":"High","gaps":["Did not test all mutants functionally for transport","In vivo splicing relevance inferred from minigenes"]},{"year":2009,"claim":"Identified membrane cholesterol as a positive kinetic modulator of BSEP transport across species and a partial rescuer of mutant activity.","evidence":"Sf9-expressed human/rat/mouse BSEP with cholesterol loading and kinetic transport assays","pmids":["19520776"],"confidence":"Medium","gaps":["Molecular mechanism of cholesterol effect on the transport cycle unknown","Single lab"]},{"year":2010,"claim":"Revealed species-specific and mRNA-versus-protein discordant cytokine regulation of BSEP, cautioning against extrapolating rodent regulation to humans.","evidence":"Sandwich-cultured human and rat hepatocytes treated with TNF-α/IL-6/IL-1β with parallel mRNA and protein quantification","pmids":["20702406"],"confidence":"Medium","gaps":["Post-transcriptional mechanism underlying protein increase not defined","Single lab"]},{"year":2011,"claim":"Established the Fyn kinase / NADPH-oxidase ROS / cortactin axis as the mechanism of hyperosmolarity-induced canalicular transporter retrieval.","evidence":"Perfused rat liver with Src-selective inhibitors, p47phox KO mice, ROS scavengers, Fyn knockdown, and cortactin phosphorylation assays","pmids":["22057277"],"confidence":"High","gaps":["How cortactin phosphorylation drives the endocytic step mechanistically unresolved","Rat liver system"]},{"year":2012,"claim":"Showed that BSEP deficiency impairs mitochondrial long-chain fatty acid β-oxidation prior to overt cholestasis, linking bile salt secretion to lipid metabolism.","evidence":"Abcb11 KO C57BL/6J mice with lipid metabolism profiling, metabolomics, and gene expression analysis","pmids":["22619174"],"confidence":"Medium","gaps":["Causal pathway from bile acid retention to β-oxidation suppression not mechanistically defined","Single lab"]},{"year":2013,"claim":"Achieved first heterologous purification of human BSEP and confirmed intrinsic ATP-binding of the isolated protein.","evidence":"Pichia pastoris expression, detergent screening, FSEC, and ATP-agarose binding","pmids":["23593265"],"confidence":"Medium","gaps":["No full functional transport reconstitution reported","No structure determined"]},{"year":2014,"claim":"Defined LKB1/AMPK-dependent microtubule trafficking through the rab11a-myosin Vb recycling endosome as the route for canalicular BSEP delivery, separable from a cAMP/PKA pathway.","evidence":"Liver-specific LKB1 KO mice, collagen sandwich hepatocytes, live-cell imaging, FRAP, particle tracking, and pharmacological pathway dissection","pmids":["24643070"],"confidence":"High","gaps":["Direct molecular link from AMPK to the trafficking machinery unresolved","Human hepatocyte confirmation not performed"]},{"year":2014,"claim":"Refined cholesterol modulation of BSEP across common variants and mutants, showing variant- and mutant-specific kinetic responses.","evidence":"Baculovirus-expressed BSEP variants/mutants in insect cells with cholesterol loading and Hanes-Woolf kinetic analysis","pmids":["24711118"],"confidence":"Medium","gaps":["Mechanistic basis of variant-specific cholesterol sensitivity unknown","Single lab"]},{"year":2020,"claim":"Demonstrated a trafficking-competent but transport-dead PFIC2 mutant (T463I) in an ATP-binding motif that is pharmacologically rescuable by ivacaftor.","evidence":"3D modelling, mutagenesis, expression in Can10 and MDCK/Ntcp cells, and ivacaftor treatment with transport assays","pmids":["32433800"],"confidence":"Medium","gaps":["Direct structural confirmation of impaired ATP binding lacking","Single mutation, single lab"]},{"year":2021,"claim":"Established a causal chain from ABCB11 deficiency through accumulation of FXR-antagonist bile acids and loss of FXR signaling to hepatocarcinogenesis, reversible by FXR agonism.","evidence":"Longitudinal Abcb11-/- mice with histology, RNA-seq, bile acid profiling, FXR activity, and obeticholic acid rescue","pmids":["34410012"],"confidence":"Medium","gaps":["Downstream FXR target genes driving transformation not pinpointed","Single lab"]},{"year":null,"claim":"The structure of human BSEP, the identity of the E3 ligase/deubiquitinase controlling its surface turnover, and the molecular coupling between trafficking signals (AMPK, Fyn/cortactin) and the endocytic/recycling machinery remain undefined.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No experimental structure of human BSEP in the corpus","Ubiquitin ligase mediating short-chain ubiquitination unidentified","Mechanistic link from retrieval signaling to membrane scission undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[0,6,7,21]},{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,6,7]},{"term_id":"GO:0140104","term_label":"molecular carrier activity","supporting_discovery_ids":[0,7]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[4,8,9,21]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[3,4,15]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[5,12]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[3,15]}],"pathway":[{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[0,7,16]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[3,4,15]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[8,11]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[16,25,27]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[5,9,23,27]}],"complexes":[],"partners":["NTCP","MRP2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O95342","full_name":"Bile salt export pump","aliases":["ATP-binding cassette sub-family B member 11"],"length_aa":1321,"mass_kda":146.4,"function":"Catalyzes the transport of the major hydrophobic bile salts, such as taurine and glycine-conjugated cholic acid across the canalicular membrane of hepatocytes in an ATP-dependent manner, therefore participates in hepatic bile acid homeostasis and consequently to lipid homeostasis through regulation of biliary lipid secretion in a bile salts dependent manner (PubMed:15791618, PubMed:16332456, PubMed:18985798, PubMed:19228692, PubMed:20010382, PubMed:20398791, PubMed:22262466, PubMed:24711118, PubMed:29507376, PubMed:32203132). Transports taurine-conjugated bile salts more rapidly than glycine-conjugated bile salts (PubMed:16332456). Also transports non-bile acid compounds, such as pravastatin and fexofenadine in an ATP-dependent manner and may be involved in their biliary excretion (PubMed:15901796, PubMed:18245269)","subcellular_location":"Apical cell membrane; Recycling endosome membrane; Endosome; Cell membrane","url":"https://www.uniprot.org/uniprotkb/O95342/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ABCB11","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ABCB11","total_profiled":1310},"omim":[{"mim_id":"619874","title":"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 11; PFIC11","url":"https://www.omim.org/entry/619874"},{"mim_id":"619868","title":"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 10; PFIC10","url":"https://www.omim.org/entry/619868"},{"mim_id":"619662","title":"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 8; PFIC8","url":"https://www.omim.org/entry/619662"},{"mim_id":"617093","title":"GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH","url":"https://www.omim.org/entry/617093"},{"mim_id":"617049","title":"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5; PFIC5","url":"https://www.omim.org/entry/617049"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Uncertain","locations":[{"location":"Nucleoplasm","reliability":"Uncertain"},{"location":"Plasma membrane","reliability":"Uncertain"},{"location":"Cytosol","reliability":"Uncertain"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"liver","ntpm":75.3}],"url":"https://www.proteinatlas.org/search/ABCB11"},"hgnc":{"alias_symbol":["ABC16","SPGP","PFIC-2","PGY4"],"prev_symbol":["BSEP","PFIC2"]},"alphafold":{"accession":"O95342","domains":[{"cath_id":"1.20.1560.10","chopping":"55-120_135-238_377-407_899-1011","consensus_level":"medium","plddt":88.4466,"start":55,"end":1011},{"cath_id":"1.20.1560.10","chopping":"240-354_744-896_1013-1060","consensus_level":"medium","plddt":88.9488,"start":240,"end":1060},{"cath_id":"3.40.50.300","chopping":"421-647","consensus_level":"medium","plddt":88.0807,"start":421,"end":647},{"cath_id":"3.40.50.300","chopping":"1079-1317","consensus_level":"medium","plddt":88.2911,"start":1079,"end":1317}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O95342","model_url":"https://alphafold.ebi.ac.uk/files/AF-O95342-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O95342-F1-predicted_aligned_error_v6.png","plddt_mean":83.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ABCB11","jax_strain_url":"https://www.jax.org/strain/search?query=ABCB11"},"sequence":{"accession":"O95342","fasta_url":"https://rest.uniprot.org/uniprotkb/O95342.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O95342/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O95342"}},"corpus_meta":[{"pmid":"10648470","id":"PMC_10648470","title":"Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver.","date":"2000","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/10648470","citation_count":428,"is_preprint":false},{"pmid":"9828229","id":"PMC_9828229","title":"Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver.","date":"1998","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/9828229","citation_count":302,"is_preprint":false},{"pmid":"18395098","id":"PMC_18395098","title":"Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families.","date":"2008","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/18395098","citation_count":277,"is_preprint":false},{"pmid":"15300568","id":"PMC_15300568","title":"Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11.","date":"2004","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/15300568","citation_count":245,"is_preprint":false},{"pmid":"11172067","id":"PMC_11172067","title":"Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis.","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11172067","citation_count":240,"is_preprint":false},{"pmid":"21103971","id":"PMC_21103971","title":"The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.","date":"2011","source":"Handbook of experimental pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/21103971","citation_count":210,"is_preprint":false},{"pmid":"15077010","id":"PMC_15077010","title":"Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy.","date":"2004","source":"Pharmacogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/15077010","citation_count":209,"is_preprint":false},{"pmid":"20232290","id":"PMC_20232290","title":"ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history.","date":"2010","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/20232290","citation_count":208,"is_preprint":false},{"pmid":"18987030","id":"PMC_18987030","title":"Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy.","date":"2008","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/18987030","citation_count":166,"is_preprint":false},{"pmid":"22795478","id":"PMC_22795478","title":"The bile salt export pump (BSEP) in health and disease.","date":"2012","source":"Clinics and research in hepatology and gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/22795478","citation_count":148,"is_preprint":false},{"pmid":"20447715","id":"PMC_20447715","title":"Differences in presentation and progression between severe FIC1 and BSEP deficiencies.","date":"2010","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/20447715","citation_count":142,"is_preprint":false},{"pmid":"19101985","id":"PMC_19101985","title":"Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicing.","date":"2009","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/19101985","citation_count":140,"is_preprint":false},{"pmid":"15205115","id":"PMC_15205115","title":"LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process.","date":"2004","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15205115","citation_count":131,"is_preprint":false},{"pmid":"14999697","id":"PMC_14999697","title":"BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis.","date":"2004","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/14999697","citation_count":129,"is_preprint":false},{"pmid":"15901796","id":"PMC_15901796","title":"Bile salt export pump (BSEP/ABCB11) can transport a nonbile acid substrate, pravastatin.","date":"2005","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/15901796","citation_count":124,"is_preprint":false},{"pmid":"12702498","id":"PMC_12702498","title":"Estradiol-17beta-D-glucuronide induces endocytic internalization of Bsep in rats.","date":"2003","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12702498","citation_count":112,"is_preprint":false},{"pmid":"28924228","id":"PMC_28924228","title":"An expanded role for heterozygous mutations of ABCB4, ABCB11, ATP8B1, ABCC2 and TJP2 in intrahepatic cholestasis of pregnancy.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28924228","citation_count":107,"is_preprint":false},{"pmid":"28733223","id":"PMC_28733223","title":"Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants.","date":"2017","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/28733223","citation_count":102,"is_preprint":false},{"pmid":"15791618","id":"PMC_15791618","title":"Two common PFIC2 mutations are associated with the impaired membrane trafficking of BSEP/ABCB11.","date":"2005","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/15791618","citation_count":94,"is_preprint":false},{"pmid":"16039748","id":"PMC_16039748","title":"Impaired expression and function of the bile salt export pump due to three novel ABCB11 mutations in intrahepatic cholestasis.","date":"2005","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/16039748","citation_count":94,"is_preprint":false},{"pmid":"20028269","id":"PMC_20028269","title":"Role of the bile salt export pump, BSEP, in acquired forms of cholestasis.","date":"2010","source":"Drug metabolism reviews","url":"https://pubmed.ncbi.nlm.nih.gov/20028269","citation_count":92,"is_preprint":false},{"pmid":"25625282","id":"PMC_25625282","title":"Identification and functional characterization of G6PC2 coding variants influencing glycemic traits define an effector transcript at the G6PC2-ABCB11 locus.","date":"2015","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25625282","citation_count":92,"is_preprint":false},{"pmid":"11745042","id":"PMC_11745042","title":"BSEP: function and role in progressive familial intrahepatic cholestasis.","date":"2001","source":"Seminars in liver disease","url":"https://pubmed.ncbi.nlm.nih.gov/11745042","citation_count":88,"is_preprint":false},{"pmid":"16156672","id":"PMC_16156672","title":"Bile acid transport in sister of P-glycoprotein (ABCB11) knockout mice.","date":"2005","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16156672","citation_count":88,"is_preprint":false},{"pmid":"12495658","id":"PMC_12495658","title":"Semi quantitative expression analysis of MDR3, FIC1, BSEP, OATP-A, OATP-C,OATP-D, OATP-E and NTCP gene transcripts in 1st and 3rd trimester human placenta.","date":"2003","source":"Placenta","url":"https://pubmed.ncbi.nlm.nih.gov/12495658","citation_count":80,"is_preprint":false},{"pmid":"16763017","id":"PMC_16763017","title":"Genetic variability, haplotype structures, and ethnic diversity of hepatic transporters MDR3 (ABCB4) and bile salt export pump (ABCB11).","date":"2006","source":"Drug metabolism and disposition: the biological fate of chemicals","url":"https://pubmed.ncbi.nlm.nih.gov/16763017","citation_count":80,"is_preprint":false},{"pmid":"14570929","id":"PMC_14570929","title":"Hepatic overexpression of murine Abcb11 increases hepatobiliary lipid secretion and reduces hepatic steatosis.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14570929","citation_count":80,"is_preprint":false},{"pmid":"17897632","id":"PMC_17897632","title":"Regulation of hepatic bile acid transporters Ntcp and Bsep expression.","date":"2007","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17897632","citation_count":74,"is_preprint":false},{"pmid":"19520776","id":"PMC_19520776","title":"Effect of membrane cholesterol on BSEP/Bsep activity: species specificity studies for substrates and inhibitors.","date":"2009","source":"Drug metabolism and disposition: the biological fate of chemicals","url":"https://pubmed.ncbi.nlm.nih.gov/19520776","citation_count":73,"is_preprint":false},{"pmid":"17855769","id":"PMC_17855769","title":"Levels of plasma membrane expression in progressive and benign mutations of the bile salt export pump (Bsep/Abcb11) correlate with severity of cholestatic diseases.","date":"2007","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17855769","citation_count":73,"is_preprint":false},{"pmid":"11815775","id":"PMC_11815775","title":"FIC1 and BSEP defects in Taiwanese patients with chronic intrahepatic cholestasis with low gamma-glutamyltranspeptidase levels.","date":"2002","source":"The Journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/11815775","citation_count":72,"is_preprint":false},{"pmid":"22619174","id":"PMC_22619174","title":"Abcb11 deficiency induces cholestasis coupled to impaired β-fatty acid oxidation in mice.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22619174","citation_count":71,"is_preprint":false},{"pmid":"11230729","id":"PMC_11230729","title":"Regulation of the dynamic localization of the rat Bsep gene-encoded bile salt export pump by anisoosmolarity.","date":"2001","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/11230729","citation_count":67,"is_preprint":false},{"pmid":"23685087","id":"PMC_23685087","title":"Biosynthesis and trafficking of the bile salt export pump, BSEP: therapeutic implications of BSEP mutations.","date":"2013","source":"Molecular aspects of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23685087","citation_count":63,"is_preprint":false},{"pmid":"16474011","id":"PMC_16474011","title":"Vectorial transport of unconjugated and conjugated bile salts by monolayers of LLC-PK1 cells doubly transfected with human NTCP and BSEP or with rat Ntcp and Bsep.","date":"2006","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16474011","citation_count":63,"is_preprint":false},{"pmid":"27593105","id":"PMC_27593105","title":"Metabolic preconditioning protects BSEP/ABCB11-/- mice against cholestatic liver injury.","date":"2016","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/27593105","citation_count":59,"is_preprint":false},{"pmid":"20702406","id":"PMC_20702406","title":"Regulation of MRP2/ABCC2 and BSEP/ABCB11 expression in sandwich cultured human and rat hepatocytes exposed to inflammatory cytokines TNF-{alpha}, IL-6, and IL-1{beta}.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20702406","citation_count":57,"is_preprint":false},{"pmid":"19008001","id":"PMC_19008001","title":"Cloning and molecular characterization of apical efflux transporters (ABCB1, ABCB11 and ABCC2) in rainbow trout (Oncorhynchus mykiss) hepatocytes.","date":"2008","source":"Aquatic toxicology (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/19008001","citation_count":56,"is_preprint":false},{"pmid":"17916651","id":"PMC_17916651","title":"Obstructive cholestasis induces TNF-alpha- and IL-1 -mediated periportal downregulation of Bsep and zonal regulation of Ntcp, Oatp1a4, and Oatp1b2.","date":"2007","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17916651","citation_count":55,"is_preprint":false},{"pmid":"26723467","id":"PMC_26723467","title":"Geniposidic acid protected against ANIT-induced hepatotoxity and acute intrahepatic cholestasis, due to Fxr-mediated regulation of Bsep and Mrp2.","date":"2015","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26723467","citation_count":53,"is_preprint":false},{"pmid":"16452108","id":"PMC_16452108","title":"Oxidative stress induces internalization of the bile salt export pump, Bsep, and bile salt secretory failure in isolated rat hepatocyte couplets: a role for protein kinase C and prevention by protein kinase A.","date":"2006","source":"Toxicological sciences : an official journal of the Society of Toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/16452108","citation_count":53,"is_preprint":false},{"pmid":"23022423","id":"PMC_23022423","title":"ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population.","date":"2012","source":"Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/23022423","citation_count":52,"is_preprint":false},{"pmid":"25342496","id":"PMC_25342496","title":"Autoimmune BSEP disease: disease recurrence after liver transplantation for progressive familial intrahepatic cholestasis.","date":"2015","source":"Clinical reviews in allergy & immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25342496","citation_count":49,"is_preprint":false},{"pmid":"20010382","id":"PMC_20010382","title":"Polymorphic variants in the human bile salt export pump (BSEP; ABCB11): functional characterization and interindividual variability.","date":"2010","source":"Pharmacogenetics and genomics","url":"https://pubmed.ncbi.nlm.nih.gov/20010382","citation_count":49,"is_preprint":false},{"pmid":"29238877","id":"PMC_29238877","title":"Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing.","date":"2017","source":"Journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/29238877","citation_count":48,"is_preprint":false},{"pmid":"11842005","id":"PMC_11842005","title":"Asynchronous expression and colocalization of Bsep and Mrp2 during development of rat liver.","date":"2002","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11842005","citation_count":47,"is_preprint":false},{"pmid":"18829893","id":"PMC_18829893","title":"Short-chain ubiquitination is associated with the degradation rate of a cell-surface-resident bile salt export pump (BSEP/ABCB11).","date":"2008","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18829893","citation_count":47,"is_preprint":false},{"pmid":"16542640","id":"PMC_16542640","title":"Effect of culture conditions on the expression and function of Bsep, Mrp2, and Mdr1a/b in sandwich-cultured rat hepatocytes.","date":"2006","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16542640","citation_count":47,"is_preprint":false},{"pmid":"30068870","id":"PMC_30068870","title":"Dysregulation of BSEP and MRP2 May Play an Important Role in Isoniazid-Induced Liver Injury via the SIRT1/FXR Pathway in Rats and HepG2 Cells.","date":"2018","source":"Biological & pharmaceutical bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/30068870","citation_count":46,"is_preprint":false},{"pmid":"17947449","id":"PMC_17947449","title":"Phenotypic differences in PFIC2 and BRIC2 correlate with protein stability of mutant Bsep and impaired taurocholate secretion in MDCK II cells.","date":"2007","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17947449","citation_count":46,"is_preprint":false},{"pmid":"25886055","id":"PMC_25886055","title":"The inhibition of hepatic bile acids transporters Ntcp and Bsep is involved in the pathogenesis of isoniazid/rifampicin-induced hepatotoxicity.","date":"2015","source":"Toxicology mechanisms and methods","url":"https://pubmed.ncbi.nlm.nih.gov/25886055","citation_count":46,"is_preprint":false},{"pmid":"20883210","id":"PMC_20883210","title":"A common polymorphism in the ABCB11 gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver disease.","date":"2011","source":"Clinical science (London, England : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/20883210","citation_count":43,"is_preprint":false},{"pmid":"26573700","id":"PMC_26573700","title":"Recent advances in the exploration of the bile salt export pump (BSEP/ABCB11) function.","date":"2015","source":"Expert opinion on therapeutic targets","url":"https://pubmed.ncbi.nlm.nih.gov/26573700","citation_count":42,"is_preprint":false},{"pmid":"17082223","id":"PMC_17082223","title":"Two N-linked glycans are required to maintain the transport activity of the bile salt export pump (ABCB11) in MDCK II cells.","date":"2006","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17082223","citation_count":42,"is_preprint":false},{"pmid":"24643070","id":"PMC_24643070","title":"LKB1/AMPK and PKA control ABCB11 trafficking and polarization in hepatocytes.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24643070","citation_count":40,"is_preprint":false},{"pmid":"22120137","id":"PMC_22120137","title":"BSEP inhibition: in vitro screens to assess cholestatic potential of drugs.","date":"2011","source":"Toxicology in vitro : an international journal published in association with BIBRA","url":"https://pubmed.ncbi.nlm.nih.gov/22120137","citation_count":40,"is_preprint":false},{"pmid":"35523117","id":"PMC_35523117","title":"Alisol B 23-acetate adjusts bile acid metabolisim via hepatic FXR-BSEP signaling activation to alleviate atherosclerosis.","date":"2022","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35523117","citation_count":40,"is_preprint":false},{"pmid":"12538788","id":"PMC_12538788","title":"Differential developmental regulation of rat liver canalicular membrane transporters Bsep and Mrp2.","date":"2003","source":"Pediatric research","url":"https://pubmed.ncbi.nlm.nih.gov/12538788","citation_count":40,"is_preprint":false},{"pmid":"16037978","id":"PMC_16037978","title":"Experimental LPS-induced cholestasis alters subcellular distribution and affects colocalization of Mrp2 and Bsep proteins: a quantitative colocalization study.","date":"2005","source":"Microscopy research and technique","url":"https://pubmed.ncbi.nlm.nih.gov/16037978","citation_count":40,"is_preprint":false},{"pmid":"26910619","id":"PMC_26910619","title":"Disruption of BSEP Function in HepaRG Cells Alters Bile Acid Disposition and Is a Susceptive Factor to Drug-Induced Cholestatic Injury.","date":"2016","source":"Molecular pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/26910619","citation_count":40,"is_preprint":false},{"pmid":"26735860","id":"PMC_26735860","title":"BSEP and MDR3: Useful Immunohistochemical Markers to Discriminate Hepatocellular Carcinomas From Intrahepatic Cholangiocarcinomas and Hepatoid Carcinomas.","date":"2016","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/26735860","citation_count":36,"is_preprint":false},{"pmid":"37601975","id":"PMC_37601975","title":"Schizophrenia-associated somatic copy-number variants from 12,834 cases reveal recurrent NRXN1 and ABCB11 disruptions.","date":"2023","source":"Cell genomics","url":"https://pubmed.ncbi.nlm.nih.gov/37601975","citation_count":35,"is_preprint":false},{"pmid":"19684528","id":"PMC_19684528","title":"Recent insights into the function and regulation of the bile salt export pump (ABCB11).","date":"2009","source":"Current opinion in lipidology","url":"https://pubmed.ncbi.nlm.nih.gov/19684528","citation_count":35,"is_preprint":false},{"pmid":"32433800","id":"PMC_32433800","title":"Functional rescue of an ABCB11 mutant by ivacaftor: A new targeted pharmacotherapy approach in bile salt export pump deficiency.","date":"2020","source":"Liver international : official journal of the International Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/32433800","citation_count":35,"is_preprint":false},{"pmid":"33070363","id":"PMC_33070363","title":"Review article: liver disease in adults with variants in the cholestasis-related genes ABCB11, ABCB4 and ATP8B1.","date":"2020","source":"Alimentary pharmacology & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/33070363","citation_count":34,"is_preprint":false},{"pmid":"20583290","id":"PMC_20583290","title":"Recurrent low gamma-glutamyl transpeptidase cholestasis following liver transplantation for bile salt export pump (BSEP) disease (posttransplant recurrent BSEP disease).","date":"2010","source":"Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society","url":"https://pubmed.ncbi.nlm.nih.gov/20583290","citation_count":34,"is_preprint":false},{"pmid":"12562825","id":"PMC_12562825","title":"Appearance of atypical 3 alpha,6 beta,7 beta,12 alpha-tetrahydroxy-5 beta-cholan-24-oic acid in spgp knockout mice.","date":"2002","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/12562825","citation_count":33,"is_preprint":false},{"pmid":"24399466","id":"PMC_24399466","title":"Hepatic bile acid metabolism and expression of cytochrome P450 and related enzymes are altered in Bsep (-/-) mice.","date":"2014","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24399466","citation_count":33,"is_preprint":false},{"pmid":"19408031","id":"PMC_19408031","title":"Common variants of ABCB4 and ABCB11 and plasma lipid levels: a study in sib pairs with gallstones, and controls.","date":"2009","source":"Lipids","url":"https://pubmed.ncbi.nlm.nih.gov/19408031","citation_count":33,"is_preprint":false},{"pmid":"31571363","id":"PMC_31571363","title":"Tanshinone IIA prevents rifampicin-induced liver injury by regulating BSEP/NTCP expression via epigenetic activation of NRF2.","date":"2019","source":"Liver international : official journal of the International Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/31571363","citation_count":32,"is_preprint":false},{"pmid":"31191298","id":"PMC_31191298","title":"Emodin Rescues Intrahepatic Cholestasis via Stimulating FXR/BSEP Pathway in Promoting the Canalicular Export of Accumulated Bile.","date":"2019","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31191298","citation_count":32,"is_preprint":false},{"pmid":"12143038","id":"PMC_12143038","title":"Ursodeoxycholic acid (UDCA) prevents DCA effects on male mouse liver via up-regulation of CYP [correction of CXP] and preservation of BSEP activities.","date":"2002","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/12143038","citation_count":32,"is_preprint":false},{"pmid":"33581308","id":"PMC_33581308","title":"Regulatory mechanisms of the bile salt export pump (BSEP/ABCB11) and its role in related diseases.","date":"2021","source":"Clinics and research in hepatology and gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/33581308","citation_count":31,"is_preprint":false},{"pmid":"27317372","id":"PMC_27317372","title":"Dioscin protects against ANIT-induced cholestasis via regulating Oatps, Mrp2 and Bsep expression in rats.","date":"2016","source":"Toxicology and applied pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27317372","citation_count":30,"is_preprint":false},{"pmid":"12739759","id":"PMC_12739759","title":"Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites.","date":"2003","source":"Pharmaceutical research","url":"https://pubmed.ncbi.nlm.nih.gov/12739759","citation_count":30,"is_preprint":false},{"pmid":"12187295","id":"PMC_12187295","title":"Effect of Ursodeoxycholic Acid on the Expression of the Hepatocellular Bile Acid Transporters (Ntcp and bsep) in Rats With Estrogen-Induced Cholestasis.","date":"2002","source":"Journal of pediatric gastroenterology and nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/12187295","citation_count":29,"is_preprint":false},{"pmid":"25016225","id":"PMC_25016225","title":"Paediatric hepatocellular carcinoma due to somatic CTNNB1 and NFE2L2 mutations in the setting of inherited bi-allelic ABCB11 mutations.","date":"2014","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/25016225","citation_count":29,"is_preprint":false},{"pmid":"23593265","id":"PMC_23593265","title":"Detergent screening and purification of the human liver ABC transporters BSEP (ABCB11) and MDR3 (ABCB4) expressed in the yeast Pichia pastoris.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23593265","citation_count":28,"is_preprint":false},{"pmid":"24711118","id":"PMC_24711118","title":"Differential effects of membrane cholesterol content on the transport activity of multidrug resistance-associated protein 2 (ABCC2) and of the bile salt export pump (ABCB11).","date":"2014","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24711118","citation_count":28,"is_preprint":false},{"pmid":"26683212","id":"PMC_26683212","title":"In vitro model systems to investigate bile salt export pump (BSEP) activity and drug interactions: A review.","date":"2015","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/26683212","citation_count":27,"is_preprint":false},{"pmid":"19845854","id":"PMC_19845854","title":"ABCB11 gene mutations in Chinese children with progressive intrahepatic cholestasis and low gamma glutamyltransferase.","date":"2009","source":"Liver international : official journal of the International Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/19845854","citation_count":26,"is_preprint":false},{"pmid":"22673116","id":"PMC_22673116","title":"Differential effect of troglitazone on the human bile acid transporters, MRP2 and BSEP, in the PXB hepatic chimeric mouse.","date":"2012","source":"Toxicologic pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22673116","citation_count":26,"is_preprint":false},{"pmid":"32141703","id":"PMC_32141703","title":"Absence of Bsep/Abcb11 attenuates MCD diet-induced hepatic steatosis but aggravates inflammation in mice.","date":"2020","source":"Liver international : official journal of the International Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/32141703","citation_count":25,"is_preprint":false},{"pmid":"25323205","id":"PMC_25323205","title":"Variations of ABCB4 and ABCB11 genes are associated with primary intrahepatic stones.","date":"2014","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/25323205","citation_count":25,"is_preprint":false},{"pmid":"15650132","id":"PMC_15650132","title":"Steatohepatitis develops rapidly in transgenic mice overexpressing Abcb11 and fed a methionine-choline-deficient diet.","date":"2005","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15650132","citation_count":25,"is_preprint":false},{"pmid":"18985798","id":"PMC_18985798","title":"Cloning of the dog bile salt export pump (BSEP; ABCB11) and functional comparison with the human and rat proteins.","date":"2008","source":"Biopharmaceutics & drug disposition","url":"https://pubmed.ncbi.nlm.nih.gov/18985798","citation_count":24,"is_preprint":false},{"pmid":"15763547","id":"PMC_15763547","title":"Silibinin prevents cholestasis-associated retrieval of the bile salt export pump, Bsep, in isolated rat hepatocyte couplets: possible involvement of cAMP.","date":"2005","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15763547","citation_count":24,"is_preprint":false},{"pmid":"34410012","id":"PMC_34410012","title":"Disordered farnesoid X receptor signaling is associated with liver carcinogenesis in Abcb11-deficient mice.","date":"2021","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/34410012","citation_count":23,"is_preprint":false},{"pmid":"22057277","id":"PMC_22057277","title":"The Src family kinase Fyn mediates hyperosmolarity-induced Mrp2 and Bsep retrieval from canalicular membrane.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22057277","citation_count":23,"is_preprint":false},{"pmid":"20723035","id":"PMC_20723035","title":"The role of bile acid retention and a common polymorphism in the ABCB11 gene as host factors affecting antiviral treatment response in chronic hepatitis C.","date":"2010","source":"Journal of viral hepatitis","url":"https://pubmed.ncbi.nlm.nih.gov/20723035","citation_count":23,"is_preprint":false},{"pmid":"33466755","id":"PMC_33466755","title":"The Bile Salt Export Pump: Molecular Structure, Study Models and Small-Molecule Drugs for the Treatment of Inherited BSEP Deficiencies.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33466755","citation_count":22,"is_preprint":false},{"pmid":"10644562","id":"PMC_10644562","title":"Bile salt excretion in skate liver is mediated by a functional analog of Bsep/Spgp, the bile salt export pump.","date":"2000","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10644562","citation_count":22,"is_preprint":false},{"pmid":"26646631","id":"PMC_26646631","title":"Yinzhihuang attenuates ANIT-induced intrahepatic cholestasis in rats through upregulation of Mrp2 and Bsep expressions.","date":"2015","source":"Pediatric research","url":"https://pubmed.ncbi.nlm.nih.gov/26646631","citation_count":21,"is_preprint":false},{"pmid":"27237619","id":"PMC_27237619","title":"Up-regulation of BSEP and MRP2 by Calculus Bovis administration in 17α-ethynylestradiol-induced cholestasis: Involvement of PI3K/Akt signaling pathway.","date":"2016","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27237619","citation_count":20,"is_preprint":false},{"pmid":"23142591","id":"PMC_23142591","title":"NR1H4 analysis in patients with progressive familial intrahepatic cholestasis, drug-induced cholestasis or intrahepatic cholestasis of pregnancy unrelated to ATP8B1, ABCB11 and ABCB4 mutations.","date":"2012","source":"Clinics and research in hepatology and gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/23142591","citation_count":20,"is_preprint":false},{"pmid":"29755014","id":"PMC_29755014","title":"Diagnosis of cirrhosis in patients with chronic hepatitis C genotype 4: Role of ABCB11 genotype polymorphism and plasma bile acid levels.","date":"2018","source":"The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/29755014","citation_count":20,"is_preprint":false},{"pmid":"28527154","id":"PMC_28527154","title":"Structure based classification for bile salt export pump (BSEP) inhibitors using comparative structural modeling of human BSEP.","date":"2017","source":"Journal of computer-aided molecular design","url":"https://pubmed.ncbi.nlm.nih.gov/28527154","citation_count":20,"is_preprint":false},{"pmid":"31258056","id":"PMC_31258056","title":"The Role of the Sodium-taurocholate Co-transporting Polypeptide (NTCP) and Bile Salt Export Pump (BSEP) in Related Liver Disease.","date":"2019","source":"Current drug metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/31258056","citation_count":19,"is_preprint":false},{"pmid":"21726512","id":"PMC_21726512","title":"Hepatic overexpression of abcb11 promotes hypercholesterolemia and obesity in mice.","date":"2011","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/21726512","citation_count":19,"is_preprint":false},{"pmid":"28262508","id":"PMC_28262508","title":"The role of Ntcp, Oatp2, Bsep and Mrp2 in liver injury induced by Dioscorea bulbifera L. and Diosbulbin B in mice.","date":"2017","source":"Environmental toxicology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28262508","citation_count":19,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":57130,"output_tokens":7779,"usd":0.144038,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17309,"output_tokens":6923,"usd":0.12981,"stage2_stop_reason":"end_turn"},"total_usd":0.273848,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"BSEP (Bsep) mediates ATP-dependent transport of monoanionic bile salts in Sf9 cell vesicles; cyclosporin A, rifamycin SV, rifampicin, and glibenclamide cis-inhibit Bsep-mediated bile salt transport; estradiol-17β-glucuronide (E217G) trans-inhibits Bsep only after its Mrp2-dependent secretion into bile canaliculi, establishing that E217G requires Mrp2 to exert its cholestatic effect on Bsep.\",\n      \"method\": \"ATP-dependent vesicle transport assays in Bsep-, Mrp2-, and Bsep/Mrp2-expressing Sf9 cells; rapid filtration technique; canalicular plasma membrane vesicles from rat liver\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted in vitro transport activity in defined expression systems, multiple orthogonal inhibitor and substrate tests, mechanistic dissection with Mrp2-deficient membranes\",\n      \"pmids\": [\"10648470\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"In endotoxin-treated rats, both mRNA and protein levels of Spgp (BSEP/ABCB11) are decreased, and the normally sharp canalicular localization shifts to a fuzzy subapical pattern, indicating that endotoxin-induced cholestasis involves both reduced BSEP expression and abnormal subcellular localization.\",\n      \"method\": \"RT-PCR, Western blotting of membrane fractions, confocal scanning laser microscopy in endotoxin-treated rats\",\n      \"journal\": \"Hepatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two orthogonal methods (protein and mRNA quantification plus immunolocalization), single lab\",\n      \"pmids\": [\"9828229\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Knockout of the spgp (Abcb11) gene in mice causes intrahepatic cholestasis with greatly reduced cholic acid secretion (~6% of wild-type); however, total bile salt output is ~30% of wild-type due to secretion of tetra-hydroxylated bile acids and an alternative canalicular transport mechanism, indicating that BSEP is the primary but not sole canalicular bile acid transporter. Abcb11 knockout also increases biliary cholesterol and phospholipid secretion, suggesting intrahepatic bile salts drive biliary lipid secretion.\",\n      \"method\": \"Targeted gene knockout in mice; bile collection and HPLC analysis of bile composition; comparison with wild-type controls\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined biliary phenotype, multiple biochemical readouts, replicated by subsequent studies\",\n      \"pmids\": [\"11172067\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"E217G induces endocytic internalization of Bsep from the canalicular membrane in rat liver, dependent on prior Mrp2-mediated secretion of E217G into bile canaliculi; dibutyryl-cAMP (DBcAMP) prevents both cholestasis and Bsep internalization by stimulating insertion of canalicular transporter-containing vesicles.\",\n      \"method\": \"Confocal microscopy and Western blotting of rat liver after E217G administration; hepatocyte couplet fluorescent bile salt accumulation assay; use of TR- (Mrp2-deficient) rats as controls\",\n      \"journal\": \"American Journal of Physiology - Gastrointestinal and Liver Physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (confocal microscopy, Western blot, functional transport assay), genetic control (Mrp2-deficient rats), replicated mechanistic finding\",\n      \"pmids\": [\"12702498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Bsep localization in rat liver is dynamically regulated by osmolarity: hypoosmolarity recruits intracellular Bsep vesicles to the canalicular membrane (choleresis), whereas hyperosmolarity causes retrieval of Bsep from the canalicular membrane (cholestasis). Bsep and Mrp2 occupy largely separate intracellular vesicle populations (colocalization in only 15% of intracellular vesicles) during retrieval.\",\n      \"method\": \"Immunohistochemistry, confocal microscopy, and densitometry in perfused rat liver under defined osmotic conditions\",\n      \"journal\": \"Hepatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization by confocal microscopy with functional bile flow correlate, single lab\",\n      \"pmids\": [\"11230729\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The two most common PFIC2 mutations E297G and D482G result in impaired membrane trafficking of BSEP: both mutants predominantly undergo only core glycosylation and are retained in the endoplasmic reticulum; proteasome inhibitor MG132 causes cellular accumulation of the core-glycosylated forms. Despite impaired trafficking, transport function (taurocholate/glycocholate) of the mutants per se is not significantly reduced.\",\n      \"method\": \"Site-directed mutagenesis of human BSEP; expression in HEK293 and MDCK II cells; membrane vesicle transport assays; glycosylation analysis; proteasome inhibition with MG132\",\n      \"journal\": \"Hepatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis combined with multiple biochemical assays (glycosylation, transport, proteasome inhibition) in two cell lines\",\n      \"pmids\": [\"15791618\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"BSEP can transport the non-bile acid substrate pravastatin in an ATP-dependent manner; human BSEP shows 3.3-fold higher relative uptake of pravastatin vs. taurocholate compared to rat Bsep; pravastatin and taurocholate competitively interact with human BSEP (Km for pravastatin ~124 µM). Several statins inhibit BSEP-mediated taurocholate transport with hydrophilic statins being weaker inhibitors.\",\n      \"method\": \"ATP-dependent uptake assay in membrane vesicles from hBSEP- and rBsep-expressing cells; competitive inhibition studies; species comparison\",\n      \"journal\": \"Journal of Pharmacology and Experimental Therapeutics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstituted transport assay with defined kinetics and competitive inhibition analysis\",\n      \"pmids\": [\"15901796\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Vectorial transcellular transport of bile salts (basal-to-apical) is reconstituted in LLC-PK1 cells co-expressing NTCP and BSEP; cells expressing only one transporter show no vectorial transport. Substrate specificity reveals BSEP preferentially transports unconjugated bile salts and glycine conjugates over taurine conjugates, with no transport of lithocholate.\",\n      \"method\": \"Double transfection of LLC-PK1 cells with human NTCP+BSEP or rat Ntcp+Bsep; directional flux measurements; substrate clearance calculations\",\n      \"journal\": \"American Journal of Physiology - Gastrointestinal and Liver Physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted vectorial transport in defined cell system, systematic substrate specificity analysis across species\",\n      \"pmids\": [\"16474011\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"N-linked glycosylation is required for BSEP protein stability, intracellular trafficking, and transport function: removal of glycans accelerates proteasomal degradation; proteins with fewer than two N-linked glycans fail to reach the apical membrane and are degraded by the proteasome (MG132-sensitive). At least two N-linked glycans (at Asn109, Asn116, Asn122, Asn125) are required for stable apical membrane expression.\",\n      \"method\": \"Site-directed mutagenesis of N-glycosylation sites in rat Bsep-YFP; expression in MDCK II cells; immunoblot, glycosidase cleavage, half-life measurements, proteasome inhibition, taurocholate transport assay\",\n      \"journal\": \"American Journal of Physiology - Gastrointestinal and Liver Physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — systematic mutagenesis of four glycosylation sites with biochemical half-life, localization, and functional transport readouts\",\n      \"pmids\": [\"17082223\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Clinical phenotype severity (PFIC2 > BRIC2) correlates with the level of BSEP plasma membrane expression: PFIC2 mutant D482G shows the greatest reduction in plasma membrane protein, while BRIC2 mutants (A570T, R1050C) show intermediate reduction. All mutants accumulate in perinuclear aggresome-like structures upon proteasome inhibition, indicating ubiquitin-dependent degradation; treatment with reduced temperature, sodium butyrate, or 4-phenylbutyrate rescues D482G surface expression.\",\n      \"method\": \"Expression of mutant rat Bsep in HEK293 cells; cell surface biotinylation; confocal microscopy; proteasome inhibition with MG132; pharmacological chaperone rescue\",\n      \"journal\": \"American Journal of Physiology - Cell Physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — systematic panel of mutations with surface biotinylation, localization, and pharmacological rescue, multiple orthogonal methods\",\n      \"pmids\": [\"17855769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"BSEP transport function is impaired in proportion to accelerated protein degradation in disease mutants; BRIC2 mutants (A570T, R1050C) retain ~50% taurocholate transport and longer half-life, while most PFIC2 mutants have near-absent transport. The C-terminal tail (R1057X truncation) is required for transport activity but not for correct targeting to the apical membrane.\",\n      \"method\": \"Mutagenesis of rat Bsep in MDCK II cells; taurocholate transport assay; protein half-life measurement; subcellular distribution by confocal microscopy in polarized monolayers\",\n      \"journal\": \"American Journal of Physiology - Gastrointestinal and Liver Physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — systematic mutant panel with transport kinetics, protein half-life, and localization in polarized cells\",\n      \"pmids\": [\"17947449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Cell-surface-resident BSEP undergoes short-chain ubiquitination (addition of 2–3 ubiquitins, shifting molecular mass from ~170 to ~190 kDa); ubiquitination accelerates BSEP degradation from the cell surface. PFIC2 mutations E297G and D482G enhance BSEP ubiquitination (increasing degradation rate), while 4-phenylbutyrate (4PBA) reduces ubiquitination and prolongs surface BSEP half-life.\",\n      \"method\": \"Ubiquitin modification assay in MDCK II cells and rat canalicular membrane vesicles; biotin-labeling of cell-surface proteins; chimeric ubiquitin-BSEP fusion construct; 4PBA treatment\",\n      \"journal\": \"Molecular Pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct biochemical demonstration of ubiquitin modification, mutagenesis, and pharmacological modulation with in vitro and in vivo corroboration\",\n      \"pmids\": [\"18829893\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"ABCB11 missense mutations and SNPs impair BSEP at two distinct levels: (1) reduced wild-type pre-mRNA splicing (up to 95% reduction in normal transcript for some mutations; D482G enhances aberrant splicing); (2) ER retention and proteasomal degradation of most missense mutant proteins. Treatment with glycerol or reduced temperature rescues processing of several mutants including E297G. Two assessed mutants (N490D, A570T) show reduced taurocholate transport activity. The SNP A444 shows reduced protein compared to V444.\",\n      \"method\": \"In vitro minigene splicing assay; expression in CHO-K1 cells; immunofluorescence for ER colocalization; glycerol/low-temperature chaperone rescue; membrane vesicle taurocholate transport assay; exogenous splicing factor addition\",\n      \"journal\": \"Hepatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — comprehensive analysis of 80% of known mutations using multiple orthogonal methods (splicing assay, protein processing, transport activity) in a single systematic study\",\n      \"pmids\": [\"19101985\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Oxidative stress internalizes Bsep from the canalicular membrane and impairs bile salt secretion through a Ca2+-dependent, PKC-mediated mechanism; PKC inhibition (H7, staurosporine, Gö6976) or PKA activation (dibutyryl-cAMP) prevents and reverses Bsep internalization and bile salt secretory failure. F-actin disarrangement accompanies Bsep internalization.\",\n      \"method\": \"Pro-oxidant treatment of isolated rat hepatocyte couplets; fluorescent bile salt analog (CLF) accumulation assay; Bsep immunofluorescence; pharmacological kinase inhibitors/activators; intracellular Ca2+ chelation\",\n      \"journal\": \"Toxicological Sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple pharmacological tools in functional assay with localization readout, single lab\",\n      \"pmids\": [\"16452108\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The Src family kinase Fyn (but not Yes or c-Src) mediates hyperosmolarity-induced retrieval of Bsep and Mrp2 from the canalicular membrane; this is driven by NADPH oxidase-derived reactive oxygen species and involves Fyn-dependent phosphorylation of cortactin underneath the canalicular membrane. JNK activation is not involved in transporter retrieval.\",\n      \"method\": \"Perfused rat liver with hyperosmotic buffer; pharmacological Src kinase inhibitors (PP-2, SU6656); p47phox knockout mice; NAC/apocynin as ROS scavengers; Fyn knockdown; cortactin phosphorylation assay; biliary excretion of fluorescent substrates\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — epistasis via genetic KO (p47phox), kinase-selective pharmacological dissection, knockdown, and functional biliary readout\",\n      \"pmids\": [\"22057277\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"LKB1 activity is required for microtubule-dependent trafficking of ABCB11 to the canalicular membrane; LKB1 knockout hepatocytes show impaired ABCB11 trafficking and canalicular network formation. In control hepatocytes, ABCB11 traffics through the rab11a–myosin Vb recycling endosomal system and its trafficking is accelerated by taurocholate (via AMPK) and cAMP (via PKA). In LKB1 KO cells, only cAMP/PKA (not taurocholate) restores trafficking.\",\n      \"method\": \"Liver-specific LKB1 knockout mice; collagen sandwich hepatocyte cultures; live cell imaging; FRAP; particle tracking; Western blotting; pharmacological cAMP and AMPK manipulation\",\n      \"journal\": \"PLoS One\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with functional phenotype, multiple live-cell imaging methods, pharmacological epistasis dissecting LKB1/AMPK vs. PKA pathways\",\n      \"pmids\": [\"24643070\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Hepatic overexpression of Abcb11 in transgenic mice increases bile flow and biliary secretion of bile salts, phosphatidylcholine, and cholesterol; it activates FXR/SHP target genes (ileal lipid-binding protein, SHP upregulated; CYP7A1 and ASBT downregulated) by increasing hydrophobic bile salt pool and FXR ligand taurodeoxycholate 4-fold. Abcb11 transgenic mice are resistant to diet-induced hepatic steatosis, establishing ABCB11 as rate-limiting for hepatobiliary bile salt secretion with downstream effects on energy homeostasis.\",\n      \"method\": \"Transthyretin-Abcb11 and BAC-Abcb11 transgenic mice; bile collection; HPLC bile salt analysis; hepatic gene expression by Northern blot/RT-PCR; lithogenic diet challenge\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two independent transgenic lines, multiple biochemical and gene expression readouts, diet challenge functional test\",\n      \"pmids\": [\"14570929\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"In spgp (Abcb11) knockout mice, elevated Mdr1 (P-glycoprotein) expression serves as an alternative bile acid transport pathway; membrane vesicles from Mdr1-overexpressing drug-resistant cells transport bile acids with ~5-fold lower affinity than Spgp, providing the first direct evidence that P-glycoprotein can transport bile acids.\",\n      \"method\": \"Western blotting of ABC transporters in Abcb11 KO mice; ATP-dependent bile acid transport assay in plasma membrane vesicles from Mdr1-overexpressing cell line\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro transport reconstitution combined with KO mouse expression data, single lab\",\n      \"pmids\": [\"16156672\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Membrane cholesterol content modulates BSEP transport kinetics: cholesterol loading increases Vmax for bile salt transport in BSEP/Bsep from all three species (human, rat, mouse) without substantially changing Km. The effect is most pronounced in rat Bsep. Cholesterol-loaded vesicles also partially rescue transport activity of disease mutants E297G and R432T.\",\n      \"method\": \"Baculovirus Sf9 expression of human/rat/mouse BSEP; cholesterol loading with cholesterol-cyclodextrin complex; kinetic transport assays with four conjugated bile salts; species-specific inhibitor IC50 determinations\",\n      \"journal\": \"Drug Metabolism and Disposition\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinetic analysis across three species with defined cholesterol manipulation, single lab\",\n      \"pmids\": [\"19520776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"LPS downregulates human MRP2 and BSEP protein in liver slices without affecting their mRNA levels, demonstrating that LPS-induced reduction of these transporters in humans occurs via posttranscriptional mechanisms (in contrast to rat, where bsep mRNA is not affected while mrp2 mRNA is reduced).\",\n      \"method\": \"Precision-cut human and rat liver slices treated with LPS; RT-PCR for mRNA; immunofluorescence microscopy for protein; nitrate/nitrite and cytokine measurements\",\n      \"journal\": \"American Journal of Physiology - Gastrointestinal and Liver Physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — parallel mRNA and protein quantification in human and rat tissue with defined species-specific conclusions, single lab\",\n      \"pmids\": [\"15205115\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Periportal downregulation of Bsep in obstructive cholestasis (bile duct ligation) is mediated by TNF-α and IL-1β: cytokine inactivation prevents periportal Bsep reduction, while portal inflammation and predominantly periportal IL-1β induction colocalizes with the zone-specific transporter changes.\",\n      \"method\": \"Bile duct ligation in rats; semiquantitative immunofluorescence with zonal analysis; cytokine neutralization with anti-TNF-α and anti-IL-1β antibodies; LPS comparison\",\n      \"journal\": \"American Journal of Physiology - Gastrointestinal and Liver Physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cytokine neutralization epistasis with spatial resolution, single lab\",\n      \"pmids\": [\"17916651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Human BSEP (ABCB11) was heterologously expressed and purified from Pichia pastoris; BSEP-GFP localizes to the plasma membrane of P. pastoris; purified BSEP in appropriate detergents binds to ATP-agarose, confirming ATP-binding capability of the isolated protein.\",\n      \"method\": \"Heterologous expression in Pichia pastoris; confocal laser scanning microscopy; detergent screening (>100 detergents); FSEC; ATP-agarose binding assay; purification yielding ~1 mg/100g wet cells\",\n      \"journal\": \"PLoS One\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — first purification of human BSEP with ATP-binding validation, single lab, no full functional reconstitution reported\",\n      \"pmids\": [\"23593265\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Membrane cholesterol differentially modulates MRP2 and BSEP transport kinetics: for BSEP variants p.V444 and p.A444, cholesterol increases Vmax without changing Km; for BSEP mutants p.E297G and p.R432T, high cholesterol increases transport activity but does not reach wild-type capacity. MRP2 cholesterol effects differ, showing cooperative kinetics for E17βG that shift to Michaelis-Menten at high cholesterol.\",\n      \"method\": \"Baculovirus expression of BSEP variants and mutants in insect cells; cholesterol loading; kinetic transport assays; Hanes-Woolf analysis\",\n      \"journal\": \"Molecular Pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — systematic kinetic analysis with defined mutants and cholesterol manipulation, single lab\",\n      \"pmids\": [\"24711118\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Novel ABCB11 mutations R432T and E297G (compound heterozygous) found in a BRIC2 patient reduce taurocholate transport to 13% and 20% of reference levels respectively in SF9 cells, while hepatic BSEP expression is preserved (unlike PFIC2 where it is absent), providing direct in vitro evidence for partial loss-of-function causing the benign rather than progressive phenotype.\",\n      \"method\": \"ABCB11 sequencing; taurocholate transport assay in SF9-transfected cells; immunohistochemistry of liver biopsy\",\n      \"journal\": \"Journal of Hepatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro functional transport assay combined with in vivo protein expression, single lab, limited to two mutations\",\n      \"pmids\": [\"16039748\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The PFIC2 mutation p.T463I (located in a conserved ABC transporter motif predicted by 3D modelling to impair ATP-binding) reduces taurocholate transport to near-zero despite normal canalicular membrane targeting; ivacaftor treatment increases transport activity of BsepT463I by 1.7-fold, restoring it to 95% of wild-type activity.\",\n      \"method\": \"3D structure modelling; site-directed mutagenesis; expression in Can10 cells (localization) and MDCK clones co-expressing rat Ntcp (transport); ivacaftor treatment; taurocholate transport assay\",\n      \"journal\": \"Liver International\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis with functional rescue by pharmacological potentiator, single lab\",\n      \"pmids\": [\"32433800\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Abcb11 knockout (C57BL/6J) mice develop cholestasis and show impaired mitochondrial long-chain fatty acid β-oxidation before the onset of cholestasis, with elevated serum free fatty acids, reduced white adipose tissue, increased fatty acid metabolites (phenylpropionylglycine, phenylacetylglycine), and reduced expression of genes for mitochondrial fatty acid oxidation.\",\n      \"method\": \"Abcb11 KO C57BL/6J mice; hepatic lipid metabolism profiling; metabolomics; gene expression analysis; serum biochemistry\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO on defined background with metabolomic and gene expression confirmation, single lab\",\n      \"pmids\": [\"22619174\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In sandwich-cultured human hepatocytes, IL-6 or IL-1β decrease BSEP mRNA while paradoxically increasing BSEP protein levels, revealing a species-specific discrepancy between mRNA and protein regulation; in rat hepatocytes, TNF-α and IL-1β decrease both Bsep mRNA and protein.\",\n      \"method\": \"Sandwich-cultured human and rat hepatocytes treated with TNF-α, IL-6, IL-1β; Western blot for protein; RT-PCR for mRNA; LPS-treated rat in vivo comparison\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — parallel mRNA/protein quantification in both species with in vivo validation in rats, single lab\",\n      \"pmids\": [\"20702406\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Abcb11-deficient mice spontaneously develop HCC and ICC after 12 months; accumulated bile acids in Abcb11-/- livers are predominantly FXR antagonists/non-agonists, causing downregulation of FXR expression and transcriptional activity; FXR agonist obeticholic acid reduces liver injury and tumor incidence in Abcb11-/- mice, establishing a causal link between ABCB11 deficiency, loss of FXR signaling, and hepatocarcinogenesis.\",\n      \"method\": \"Abcb11-/- mice followed longitudinally; liver histology; RNA-sequencing; bile acid profiling; FXR activity measurement; obeticholic acid treatment rescue experiment\",\n      \"journal\": \"Journal of Pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mouse with pharmacological rescue (FXR agonist) and transcriptomic mechanism, single lab\",\n      \"pmids\": [\"34410012\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ABCB11/BSEP is an ATP-binding cassette transporter exclusively expressed at the hepatocyte canalicular membrane where it constitutes the rate-limiting step for bile salt secretion into bile; its transport activity requires at least two N-linked glycans for protein stability and correct trafficking, is regulated by ubiquitin-mediated proteasomal degradation at the cell surface (modulated by disease mutations and 4-phenylbutyrate), is dynamically retrieved from or inserted into the canalicular membrane by osmolarity (via Fyn kinase/ROS), cAMP/PKA, LKB1/AMPK, and endocytic pathways (triggered by oxidative stress, cholestatic agents such as E217G via Mrp2, and inflammatory cytokines via posttranscriptional mechanisms), and its deficiency causes progressive intrahepatic cholestasis, impaired fatty acid β-oxidation, and—through accumulation of FXR-antagonist bile acids—hepatocarcinogenesis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ABCB11 (BSEP/Spgp) is the ATP-dependent canalicular transporter that constitutes the rate-limiting step for hepatocyte secretion of monoanionic bile salts into bile, driving overall bile flow and biliary lipid secretion [#0, #16]. Reconstituted in vitro and in double-transfected polarized cells, it mediates vectorial basal-to-apical bile salt transport in concert with the uptake transporter NTCP, preferring unconjugated and glycine-conjugated bile salts and also handling non-bile-acid substrates such as pravastatin [#6, #7]. Genetic ablation establishes BSEP as the primary but not sole canalicular bile acid pump, with residual output sustained by tetrahydroxylated bile acids and an alternative Mdr1/P-glycoprotein-mediated pathway [#2, #17]. Its activity is tuned at the membrane by cholesterol content, which raises transport Vmax [#18, #22]. BSEP biogenesis and surface residence are tightly controlled: at least two N-linked glycans are required for stability and apical targeting, and surface protein is removed by short-chain ubiquitination and proteasomal degradation, a process accelerated by disease mutations and slowed by 4-phenylbutyrate [#8, #11]. Surface abundance is further set by dynamic vesicular retrieval and insertion governed by osmolarity acting through Fyn kinase and NADPH-oxidase-derived ROS, by cAMP/PKA-stimulated insertion, and by LKB1/AMPK-dependent microtubule trafficking through the rab11a–myosin Vb recycling endosome [#3, #4, #14, #15]. Mutations in ABCB11 cause progressive (PFIC2) and benign recurrent (BRIC2) intrahepatic cholestasis, with severity tracking the degree of misprocessing, accelerated degradation, and loss of plasma-membrane expression [#5, #9, #12, #23]. Beyond cholestasis, BSEP deficiency impairs mitochondrial fatty acid \\u03b2-oxidation and, through accumulation of FXR-antagonist bile acids and loss of FXR signaling, promotes hepatocarcinogenesis [#25, #27].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Established that BSEP is a bona fide ATP-dependent bile salt transporter and dissected how a co-secreted compound exerts trans-inhibition only after Mrp2-dependent biliary delivery.\",\n      \"evidence\": \"ATP-dependent vesicle transport assays in Bsep/Mrp2-expressing Sf9 cells and rat canalicular membrane vesicles with inhibitor panels\",\n      \"pmids\": [\"10648470\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve transport stoichiometry or structural basis of substrate recognition\", \"Mechanism of E217G internalization not addressed at this stage\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Defined BSEP's in vivo role by showing knockout causes intrahepatic cholestasis yet retains partial bile salt output, revealing BSEP is the primary but not exclusive canalicular bile acid transporter.\",\n      \"evidence\": \"Targeted Abcb11 knockout mice with bile collection and HPLC composition analysis\",\n      \"pmids\": [\"11172067\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the alternative transporter unresolved at this point\", \"Did not address human phenotype correspondence\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Showed that BSEP surface abundance is dynamically set by membrane retrieval/insertion rather than fixed, linking osmolarity to bile flow.\",\n      \"evidence\": \"Immunohistochemistry and confocal microscopy in perfused rat liver under defined osmotic conditions\",\n      \"pmids\": [\"11230729\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Signaling intermediates linking osmolarity to retrieval not identified\", \"Single lab, localization-based readout\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrated cAMP-stimulated vesicular insertion of BSEP and identified endocytic internalization as a reversible cholestatic mechanism.\",\n      \"evidence\": \"Confocal microscopy, Western blot, and hepatocyte couplet transport assays in rat liver with Mrp2-deficient controls\",\n      \"pmids\": [\"12702498\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endocytic machinery components not identified\", \"Did not define the kinase cascade downstream of cAMP\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Established ABCB11 as rate-limiting for hepatobiliary bile salt secretion with downstream FXR/SHP and energy-homeostasis consequences.\",\n      \"evidence\": \"Two independent Abcb11 transgenic mouse lines with bile analysis, hepatic gene expression, and lithogenic diet challenge\",\n      \"pmids\": [\"14570929\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking bile salt pool to systemic energy metabolism only correlative\", \"FXR ligand changes inferred from pool composition\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Defined the molecular basis of PFIC2 mutations E297G/D482G as trafficking defects (ER retention, core glycosylation, proteasomal degradation) rather than intrinsic transport loss.\",\n      \"evidence\": \"Site-directed mutagenesis in HEK293/MDCK cells with glycosylation analysis, transport assays, and MG132 proteasome inhibition\",\n      \"pmids\": [\"15791618\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase mediating degradation not identified\", \"Did not test pharmacological chaperone rescue\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Broadened BSEP substrate range to non-bile-acid compounds and quantified statin interactions relevant to drug-induced cholestasis.\",\n      \"evidence\": \"ATP-dependent vesicle uptake assays with kinetic and competitive inhibition analysis across human and rat orthologs\",\n      \"pmids\": [\"15901796\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of pravastatin transport not established\", \"Structural basis of statin inhibition unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Provided direct in vitro evidence that P-glycoprotein/Mdr1 is the compensatory alternative bile acid transporter upregulated in BSEP deficiency.\",\n      \"evidence\": \"Western blotting of Abcb11 KO mice plus ATP-dependent bile acid transport in Mdr1-overexpressing membrane vesicles\",\n      \"pmids\": [\"16156672\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological contribution in vivo not quantified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Linked partial loss-of-function transport defects to the milder BRIC2 phenotype, distinguishing it from PFIC2 by preserved hepatic BSEP expression.\",\n      \"evidence\": \"ABCB11 sequencing with taurocholate transport assays in Sf9 cells and liver biopsy immunohistochemistry\",\n      \"pmids\": [\"16039748\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Limited to two mutations\", \"Single patient/lab\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Reconstituted vectorial transcellular bile salt transport and defined BSEP substrate preference, establishing the NTCP-BSEP axis.\",\n      \"evidence\": \"Double-transfected LLC-PK1 cells with directional flux and substrate clearance measurements\",\n      \"pmids\": [\"16474011\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address regulation of the coupled system\", \"Lithocholate handling left unexplained mechanistically\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Established N-linked glycosylation as a determinant of BSEP stability, trafficking, and function, with at least two glycans required for apical expression.\",\n      \"evidence\": \"Site-directed mutagenesis of glycosylation sites in rat Bsep-YFP in MDCK cells with half-life, localization, glycosidase, and transport readouts\",\n      \"pmids\": [\"17082223\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which glycan-recognizing quality-control machinery acts on BSEP not identified\", \"Did not address glycan role in human disease variants\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identified oxidative stress as an internalizing stimulus acting through a Ca2+/PKC pathway reversible by PKA, with cytoskeletal involvement.\",\n      \"evidence\": \"Pro-oxidant treatment of rat hepatocyte couplets with kinase inhibitors/activators, Ca2+ chelation, and Bsep immunofluorescence\",\n      \"pmids\": [\"16452108\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular link between PKC and the endocytic machinery undefined\", \"Pharmacological inhibitors lack absolute specificity\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Connected clinical severity to the level of BSEP plasma-membrane expression and demonstrated ubiquitin-dependent degradation with pharmacological chaperone rescue.\",\n      \"evidence\": \"Mutant rat Bsep in HEK293 cells with surface biotinylation, confocal imaging, MG132, and temperature/4PBA/butyrate rescue\",\n      \"pmids\": [\"17855769\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific ubiquitin ligase not identified\", \"Rat ortholog used as surrogate for human variants\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Showed transport function declines in proportion to accelerated degradation and mapped the C-terminal tail as required for transport but not targeting.\",\n      \"evidence\": \"Mutant rat Bsep in MDCK cells with transport kinetics, half-life, and polarized localization\",\n      \"pmids\": [\"17947449\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural role of the C-terminus in the transport cycle unresolved\", \"Rat surrogate system\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identified TNF-\\u03b1 and IL-1\\u03b2 as mediators of zone-specific periportal BSEP downregulation in obstructive cholestasis.\",\n      \"evidence\": \"Bile duct ligation in rats with zonal immunofluorescence and cytokine neutralization\",\n      \"pmids\": [\"17916651\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Intracellular signaling from cytokine to transporter loss not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Directly demonstrated short-chain ubiquitination of cell-surface BSEP as the degradation signal, modulated by disease mutations and 4PBA.\",\n      \"evidence\": \"Ubiquitin modification assays in MDCK cells and rat canalicular vesicles with surface biotinylation, chimeric ubiquitin-BSEP, and 4PBA treatment\",\n      \"pmids\": [\"18829893\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Responsible ubiquitin ligase and deubiquitinase unidentified\", \"Recognition signal on BSEP not mapped\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Systematically dissected ABCB11 mutations into pre-mRNA splicing defects versus protein ER-retention/degradation defects, with chaperone-rescuable subsets.\",\n      \"evidence\": \"Minigene splicing assays, CHO-K1 expression with ER colocalization, glycerol/temperature rescue, and transport assays across most known mutations\",\n      \"pmids\": [\"19101985\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not test all mutants functionally for transport\", \"In vivo splicing relevance inferred from minigenes\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identified membrane cholesterol as a positive kinetic modulator of BSEP transport across species and a partial rescuer of mutant activity.\",\n      \"evidence\": \"Sf9-expressed human/rat/mouse BSEP with cholesterol loading and kinetic transport assays\",\n      \"pmids\": [\"19520776\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism of cholesterol effect on the transport cycle unknown\", \"Single lab\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Revealed species-specific and mRNA-versus-protein discordant cytokine regulation of BSEP, cautioning against extrapolating rodent regulation to humans.\",\n      \"evidence\": \"Sandwich-cultured human and rat hepatocytes treated with TNF-\\u03b1/IL-6/IL-1\\u03b2 with parallel mRNA and protein quantification\",\n      \"pmids\": [\"20702406\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Post-transcriptional mechanism underlying protein increase not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Established the Fyn kinase / NADPH-oxidase ROS / cortactin axis as the mechanism of hyperosmolarity-induced canalicular transporter retrieval.\",\n      \"evidence\": \"Perfused rat liver with Src-selective inhibitors, p47phox KO mice, ROS scavengers, Fyn knockdown, and cortactin phosphorylation assays\",\n      \"pmids\": [\"22057277\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How cortactin phosphorylation drives the endocytic step mechanistically unresolved\", \"Rat liver system\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Showed that BSEP deficiency impairs mitochondrial long-chain fatty acid \\u03b2-oxidation prior to overt cholestasis, linking bile salt secretion to lipid metabolism.\",\n      \"evidence\": \"Abcb11 KO C57BL/6J mice with lipid metabolism profiling, metabolomics, and gene expression analysis\",\n      \"pmids\": [\"22619174\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal pathway from bile acid retention to \\u03b2-oxidation suppression not mechanistically defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Achieved first heterologous purification of human BSEP and confirmed intrinsic ATP-binding of the isolated protein.\",\n      \"evidence\": \"Pichia pastoris expression, detergent screening, FSEC, and ATP-agarose binding\",\n      \"pmids\": [\"23593265\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No full functional transport reconstitution reported\", \"No structure determined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Defined LKB1/AMPK-dependent microtubule trafficking through the rab11a-myosin Vb recycling endosome as the route for canalicular BSEP delivery, separable from a cAMP/PKA pathway.\",\n      \"evidence\": \"Liver-specific LKB1 KO mice, collagen sandwich hepatocytes, live-cell imaging, FRAP, particle tracking, and pharmacological pathway dissection\",\n      \"pmids\": [\"24643070\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular link from AMPK to the trafficking machinery unresolved\", \"Human hepatocyte confirmation not performed\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Refined cholesterol modulation of BSEP across common variants and mutants, showing variant- and mutant-specific kinetic responses.\",\n      \"evidence\": \"Baculovirus-expressed BSEP variants/mutants in insect cells with cholesterol loading and Hanes-Woolf kinetic analysis\",\n      \"pmids\": [\"24711118\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanistic basis of variant-specific cholesterol sensitivity unknown\", \"Single lab\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrated a trafficking-competent but transport-dead PFIC2 mutant (T463I) in an ATP-binding motif that is pharmacologically rescuable by ivacaftor.\",\n      \"evidence\": \"3D modelling, mutagenesis, expression in Can10 and MDCK/Ntcp cells, and ivacaftor treatment with transport assays\",\n      \"pmids\": [\"32433800\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct structural confirmation of impaired ATP binding lacking\", \"Single mutation, single lab\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Established a causal chain from ABCB11 deficiency through accumulation of FXR-antagonist bile acids and loss of FXR signaling to hepatocarcinogenesis, reversible by FXR agonism.\",\n      \"evidence\": \"Longitudinal Abcb11-/- mice with histology, RNA-seq, bile acid profiling, FXR activity, and obeticholic acid rescue\",\n      \"pmids\": [\"34410012\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream FXR target genes driving transformation not pinpointed\", \"Single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structure of human BSEP, the identity of the E3 ligase/deubiquitinase controlling its surface turnover, and the molecular coupling between trafficking signals (AMPK, Fyn/cortactin) and the endocytic/recycling machinery remain undefined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No experimental structure of human BSEP in the corpus\", \"Ubiquitin ligase mediating short-chain ubiquitination unidentified\", \"Mechanistic link from retrieval signaling to membrane scission undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [0, 6, 7, 21]},\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 6, 7]},\n      {\"term_id\": \"GO:0140104\", \"supporting_discovery_ids\": [0, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [4, 8, 9, 21]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [3, 4, 15]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [5, 12]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [3, 15]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 7, 16]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [3, 4, 15]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [8, 11]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [16, 25, 27]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [5, 9, 23, 27]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"NTCP\", \"MRP2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}